Daiichi Sankyo (Germany)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi Sankyo (Germany), Germany, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
62%
Total
Publications
2K
Total Open
Publications
1.3K
Total
Citations
54K
Open Access
Percentage
62%
Total
Publications
2K
Total Open
Publications
1.3K
Total
Citations
54K
Breakdown
Publisher Open
34%
Both
21%
Other Platform Open
7%
Closed
38%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 25%
279
Hybrid 24%
260
No Guarantees 51%
566
Other Platform Open
Domain 65%
369
Institution 41%
232
Other Internet 21%
119
Preprint 4%
24
Public 1%
7
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 379 |
doaj.org OAI-PMH Repository | Institution | 108 |
DOI | Other Internet | 93 |
Unknown Repository | Other Internet | 31 |
Royal Netherlands Academy of Arts and Sciences | Institution | 21 |
University of Birmingham | Institution | 19 |
National Institute of Informatics | Institution | 19 |
Research Square | Preprint | 17 |
Europe PMC | Domain | 14 |
Leiden University | Institution | 10 |